Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL)

NCT02723448 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT02723448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02723448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy (RVCL)
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
December 5, 2016
Completion date
July 23, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebroretinal vasculopathy, hereditary, vasculopathy, retinal, with cerebral leukodystrophy